167 related articles for article (PubMed ID: 38399534)
1. Assessment of Radiation Dosage to the Hippocampi during Treatment of Multiple Brain Metastases Using Gamma Knife Therapy.
Laskowski M; Błaszczyk B; Setlak M; Kuca M; Lech A; Kłos K; Rudnik A
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399534
[No Abstract] [Full Text] [Related]
2. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
[TBL] [Abstract][Full Text] [Related]
3. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
4. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose and incidence of new metastasis in the anterior temporal lobe structures of radiosurgically treated patients.
Basina BR; Olson C; Roy DK; Yen CP; Schlesinger D; Nagayama K; Sheehan JP
J Neurosurg; 2010 Jan; 112(1):122-9. PubMed ID: 19499979
[TBL] [Abstract][Full Text] [Related]
6. Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort.
Skeie BS; Eide GE; Flatebø M; Heggdal JI; Larsen E; Bragstad S; Pedersen PH; Enger PØ
J Neurosurg; 2017 Mar; 126(3):708-725. PubMed ID: 27058206
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
[TBL] [Abstract][Full Text] [Related]
8. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
9. Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole Brain Radiation Therapy for Patients With 10 to 30 Brain Metastases: A Dosimetric Analysis.
Nguyen TK; Sahgal A; Detsky J; Soliman H; Myrehaug S; Tseng CL; Husain ZA; Carty A; Das S; Yang V; Lee Y; Sarfehnia A; Chugh BP; Yeboah C; Ruschin M
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):394-399. PubMed ID: 31283978
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
11. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors.
Elaimy AL; Mackay AR; Lamoreaux WT; Fairbanks RK; Demakas JJ; Cooke BS; Lee CM
World Neurosurg; 2011; 75(5-6):673-83. PubMed ID: 21704935
[TBL] [Abstract][Full Text] [Related]
13. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
14. How many brain metastases can be treated with stereotactic radiosurgery before the radiation dose delivered to normal brain tissue rivals that associated with standard whole brain radiotherapy?
Becker SJ; Lipson EJ; Jozsef G; Molitoris JK; Silverman JS; Presser J; Kondziolka D
J Appl Clin Med Phys; 2023 Mar; 24(3):e13856. PubMed ID: 36628586
[TBL] [Abstract][Full Text] [Related]
15. Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis.
Nicosia L; Figlia V; Mazzola R; Napoli G; Giaj-Levra N; Ricchetti F; Rigo M; Lunardi G; Tomasini D; Bonù ML; Corradini S; Ruggieri R; Alongi F
Clin Exp Metastasis; 2020 Feb; 37(1):77-83. PubMed ID: 31691873
[TBL] [Abstract][Full Text] [Related]
16. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
17. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
Colaco RJ; Martin P; Kluger HM; Yu JB; Chiang VL
J Neurosurg; 2016 Jul; 125(1):17-23. PubMed ID: 26544782
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
19. Three-stage Gamma Knife treatment for metastatic brain tumors larger than 10 cm3: a 2-institute study including re-analyses of earlier results using competing risk analysis.
Yamamoto M; Higuchi Y; Serizawa T; Kawabe T; Nagano O; Sato Y; Koiso T; Watanabe S; Aiyama H; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):77-85. PubMed ID: 30544297
[TBL] [Abstract][Full Text] [Related]
20. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
